Stock Screener App

Frei -

Installieren

2.22

5.53% -0.13

after-market

Handel nachbörslich: 2.22

Atossa Therapeutics Inc (ATOS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	2.33% 9.251	9.04	7.414	7.151	6.385
Operating Income/Loss	2.33% -9.251	-9.04	-7.414	-7.151	-6.385
Income/Loss From Continuing Operations Before Tax	3.19% -8.692	-8.423	-6.718	-6.347	-7.23
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	3.19% -8.692	-8.423	-6.718	-6.347	-7.23
Net Income/Loss	3.19% -8.692	-8.423	-6.718	-6.347	-7.23
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.00% 129.17	129.17	129.17	0.2505	125.77
Diluted Average Shares	0.00% 129.17	129.17	129.17	0.2505	125.77
Basic Earnings Per Share	0.00% -0.07	-0.07	-0.05	-0.05	-0.06
Diluted Earnings Per Share	0.00% -0.07	-0.07	-0.05	-0.05	-0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$30.41

1.27%

MRNA

$55.40

6.27%

BNTX

$89.50

1.43%

RPRX

$54.21

0.11%

ONC

$263.92

1.60%

RVMD

$156.58

2.17%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters